March 27, 2019
CSP Announces Webcast for Members on HER2 Testing in Breast Cancer | April 4, 2019

We are pleased to announce this free webcast for members on Thursday April 4, 2019 from 12 noon - 1:00 pm. It is non-branded and you can register directly on the link provided below.

Because of the recent FDA approval, this unbranded, case based discussion will highlight PD-L1 testing in metastatic Triple Negative Breast Cancer along with the 2018 ASCO/CAP Her2 breast cancer testing guideline recommendations. Discussion topics will include:
  • Biological implications of PD-L1 expression in cancer
  • Describe testing algorithm and sample preparation in TNBC
  • Practical implications of the 2018 update to the ASCO/CAP guidelines
  • Importance of multidisciplinary collaboration to enhance quality testing



California Society of Pathologists
One Capitol Mall Suite 800
Sacramento, CA 95814 
Tel : 916-446-6001
Fax :  916-444-7462